Pharmaceutical Tablet Supplier – Metoprolol Tartrate

The contract seeks suppliers to provide FDA-compliant Metoprolol Tartrate tablets packaged in sealed unit containers designed for long-term storage and secure transportation, ensuring full adherence to federal drug standards and labeling regulations. All products must meet stringent quality and safety requirements to support reliable distribution through military and federal healthcare channels, with no tolerance for deviations in composition, packaging integrity, or compliance documentation. This is a subcontract opportunity under the NAICS code 325412, issued by the Department of Defense through the Medical Supply Chain Pharm FSA, with bids due by July 27, 2026. The procurement is intended to sustain a robust pharmaceutical supply chain for critical cardiovascular medications within defense medical operations, requiring suppliers to demonstrate proven capability in manufacturing, packaging, and delivering sterile, stable tablet formulations that comply with all applicable federal pharmacopeial and regulatory norms. The exact delivery location and point of contact are not specified, but responses must be submitted via the designated DIBBS portal.